Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexRUT P/E98.62 EPS (ttm)0.13 Insider Own0.42% Shs Outstand131.34M Perf Week0.47%
Market Cap1.69B Forward P/E50.72 EPS next Y0.25 Insider Trans0.00% Shs Float130.91M Perf Month-1.23%
Income20.48M PEG- EPS next Q0.04 Inst Own103.79% Short Float16.04% Perf Quarter17.78%
Sales260.81M P/S6.48 EPS this Y496.00% Inst Trans1.13% Short Ratio9.59 Perf Half Y6.29%
Book/sh5.19 P/B2.48 EPS next Y27.95% ROA2.01% Short Interest21.00M Perf Year-3.46%
Cash/sh5.81 P/C2.21 EPS next 5Y- ROE3.18% 52W Range9.74 - 15.01 Perf YTD-8.08%
Dividend Est.- P/FCF74.51 EPS past 5Y54.52% ROI2.20% 52W High-14.39% Beta1.34
Dividend TTM- Quick Ratio12.34 Sales past 5Y239.63% Gross Margin82.85% 52W Low31.93% ATR (14)0.39
Dividend Ex-Date- Current Ratio13.23 EPS Y/Y TTM-67.40% Oper. Margin-2.85% RSI (14)57.65 Volatility2.34% 3.45%
Employees408 Debt/Eq0.37 Sales Y/Y TTM-27.79% Profit Margin7.85% Recom1.33 Target Price23.80
Option/ShortYes / Yes LT Debt/Eq0.37 EPS Q/Q22.55% Payout- Rel Volume0.56 Prev Close12.84
Sales Surprise-4.20% EPS Surprise5.91% Sales Q/Q15.99% EarningsNov 07 AMC Avg Volume2.19M Price12.85
SMA201.07% SMA508.17% SMA20010.78% Trades Volume1,225,382 Change0.08%
Date Action Analyst Rating Change Price Target Change
Feb-01-24Initiated Goldman Neutral $20
Sep-27-22Initiated JMP Securities Mkt Outperform $22
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
Nov-27-24 09:55AM
Nov-26-24 04:05PM
Nov-25-24 09:03AM
Nov-19-24 08:50AM
Nov-11-24 12:00PM
09:55AM Loading…
09:55AM
08:00AM
Nov-08-24 12:02PM
Nov-07-24 11:15PM
05:25PM
04:18PM
04:02PM
04:01PM
Nov-01-24 06:33PM
Oct-29-24 08:30AM
09:08PM Loading…
Oct-24-24 09:08PM
04:10PM
Oct-16-24 01:04PM
Oct-09-24 05:07PM
Sep-20-24 06:39PM
Sep-16-24 07:02PM
Sep-12-24 01:13AM
Sep-05-24 08:30AM
Aug-09-24 09:55AM
Aug-06-24 11:30PM
07:10PM
06:11PM
04:01PM
Jul-23-24 04:00PM
Jun-28-24 04:32AM
04:09PM Loading…
Jun-27-24 04:09PM
May-28-24 04:18PM
May-14-24 09:59AM
08:55AM
08:30AM
May-10-24 01:43PM
May-09-24 01:58PM
03:40AM
02:15AM
May-08-24 08:59PM
05:20PM
04:17PM
04:01PM
Apr-24-24 04:05PM
Apr-21-24 10:39AM
Mar-04-24 11:53PM
08:28PM
Feb-27-24 06:54PM
Feb-23-24 10:34AM
06:38AM
Feb-22-24 08:00PM
05:15PM
04:44PM
04:01PM
Feb-08-24 04:15PM
Jan-08-24 10:58PM
09:00AM
Jan-05-24 08:50AM
03:03AM
Jan-03-24 06:33PM
Dec-05-23 09:55AM
Nov-24-23 09:40AM
Nov-20-23 05:04PM
Nov-07-23 09:40AM
Nov-04-23 09:02AM
Nov-03-23 12:28PM
10:46AM
05:31AM
Nov-02-23 06:22PM
04:39PM
04:01PM
11:23AM
Nov-01-23 12:03PM
Oct-30-23 10:00AM
Oct-26-23 04:15PM
12:00PM
10:02AM
Oct-24-23 07:45AM
Oct-19-23 01:15PM
06:32AM
Oct-16-23 09:55AM
08:50AM
Oct-12-23 10:42AM
Oct-11-23 09:24AM
Oct-05-23 05:01AM
Sep-29-23 09:55AM
08:50AM
Sep-28-23 11:18AM
10:48AM
Sep-26-23 11:49AM
Sep-21-23 09:19AM
Sep-20-23 07:51AM
Sep-18-23 09:16AM
Sep-14-23 09:36AM
Sep-12-23 08:26AM
07:54AM
Sep-11-23 12:31PM
08:21AM
Sep-08-23 07:06PM
Sep-07-23 08:43AM
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CANO FRANCISDirectorMay 31 '24Sale11.933,61543,12736,905Jun 03 05:37 PM
CANO FRANCISDirectorMay 24 '24Option Exercise5.907,50044,25044,405May 28 08:18 PM
Burgess JustinChief Accounting OfficerMar 01 '24Option Exercise10.457,10174,23220,526Mar 04 05:25 PM
Burgess JustinChief Accounting OfficerMar 01 '24Sale12.7820,526262,3220Mar 04 05:25 PM
Janssen RobertSVP and CMOJan 04 '24Option Exercise9.411,50014,11551,425Jan 08 06:48 PM
Janssen RobertSVP and CMOJan 04 '24Sale15.001,50022,50049,925Jan 08 06:48 PM
Novack David FPresident & COOJan 02 '24Option Exercise5.429,00048,78012,187Jan 04 07:04 PM
Novack David FPresident & COOJan 02 '24Sale14.459,000130,0503,187Jan 04 07:04 PM